AMGN vs SCNX · P/E 24, rev $10.05B vs rev $400.0K
Amgen Inc (AMGN) versus Scienture Holdings, Inc. (SCNX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Scienture Holdings, Inc. (SCNX) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SCNX revenue for 2026-06-30 was $400.0K. Net income was -$6.2M. SCNX currently screens at market cap $15.8M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SCNX currently screens at market cap $15.8M.
Not investment advice. Open the AMGN and SCNX stock pages for the full models.
Not investment advice.